SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan
0 references·15 citing·34 second hop
High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan (2003)High throughput screening of 16 million s…First report of human immunodeficiency virus transmission via a blood donation that tested negative by 20‐minipool nucleic acid amplification in J apan (2014)First report of human immunod…Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan (2014)Estimating window period bloo…Patterns of infective sero positivity among blood donors in a rural Medical College Regional Blood Transfusion centre: A retrospective study (2013)Patterns of infective sero po…Molecular virology in transfusion medicine laboratory. (2013)Molecular virology in transfu…Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections (2012)Need for Nucleic Acid Testing…Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti‐HBc titres or high anti‐HBc titres with high anti‐HBs titres in Japan: a prospective, individual NAT study of transfusion‐transmitted HBV, HCV and HIV infections (2011)Significant background rates …Informative Dorfman Screening (2011)Informative Dorfman ScreeningInfectivity of HBV DNA positive donations identified in look‐back studies in Hyogo‐Prefecture, Japan (2010)Infectivity of HBV DNA positi…Improving blood donor screening by nucleic acid technology (NAT) (2010)Improving blood donor screeni…Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Multicenter evaluation of ind…Hepatitis B virus blood screening: unfinished agendas (2006)Hepatitis B virus blood scree…Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA (2006)Evaluation of a new molecular…Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Multicenter performance evalu…Infectious Risks Associated with the Transfusion of Blood Components and Pathogen Inactivation in Japan (2004)Infectious Risks Associated w…Emerging infections in transfusion medicine (2004)Emerging infections in transf…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)The Cambridge Ancient History (1971)The Risk of Transfusion-Transmitted Viral Infections (1996)International application of the Incidence Rate/Window Period model (2002)Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand (2007)Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Transfusion-transmitted infections (2007)Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997 (2000)Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997 (2000)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India (2017)The use of a square array scheme in blood testing (1994)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Optimal Retesting Configurations for Hierarchical Group Testing (2015)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Developing an administrative plan for transfusion medicine—a global perspective (2005)Transfusion Transmitted Infections in Armed Forces: Prevalence and Trends (2006)A 10 Years Comparative Study to Assess Trends in Seroprevalence of Transfusion Transmitted Infections among Blood Donors at Gwalior, India (2014)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. (2015)Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting (2022)Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan (2023)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2011Informative Dorfman Screening97 cited
  • 2006Hepatitis B virus blood screening: unfinished agendas94 cited
  • 2008Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.73 cited
  • 2005Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations56 cited
  • 2012Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections48 cited
  • 2004Emerging infections in transfusion medicine34 cited
  • 2006Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA25 cited
  • 2014Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan19 cited
  • 2004Infectious Risks Associated with the Transfusion of Blood Components and Pathogen Inactivation in Japan17 cited
  • 2013Molecular virology in transfusion medicine laboratory.15 cited
  • 2013Patterns of infective sero positivity among blood donors in a rural Medical College Regional Blood Transfusion centre: A retrospective study14 cited
  • 2010Improving blood donor screening by nucleic acid technology (NAT)

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

12 cited
  • 2011Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti‐HBc titres or high anti‐HBc titres with high anti‐HBs titres in Japan: a prospective, individual NAT study of transfusion‐transmitted HBV, HCV and HIV infections10 cited
  • 2014First report of human immunodeficiency virus transmission via a blood donation that tested negative by 20‐minipool nucleic acid amplification in J apan9 cited
  • 2010Infectivity of HBV DNA positive donations identified in look‐back studies in Hyogo‐Prefecture, Japan9 cited